| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 380,833 | 416,997 | 398,577 | 350,652 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 416,997 | 398,577 | 350,652 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 142,083 | 334,885 | 338,439 | 329,863 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 208,553 | 26,184 | 23,293 | 21,952 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,197 | 55,928 | 36,845 | (1,163) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 30,197 | 55,928 | 36,845 | (1,163) | | Interest Expense | 7,053 | 7,117 | 7,225 | 8,001 | | Income Before Tax | 23,144 | 48,811 | 29,620 | (9,164) | | Income Tax Expense | 2,321 | 11,804 | 5,136 | (7,638) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,823 | 37,007 | 24,484 | (1,526) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,823 | 37,007 | 24,484 | (1,526) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,823 | $37,007 | $24,484 | ($1,526) |
|
0.01% Nasdaq 
0.22%
Income Statement
